Previous Page  22 / 27 Next Page
Information
Show Menu
Previous Page 22 / 27 Next Page
Page Background

Page 78

allied

academies

J Pharmacol Ther Res 2017 Volume 1 Issue 2

November 02-03, 2017 Chicago, USA

4

th

International Congress on

International Conference and Exhibition on

Drug Discovery, Designing and Development

Biochemistry, Molecular Biology: R&D

&

S

ilicateins play the major role in formation of silica skeletal

structures in marine sponges. They are members of the

cathepsin family of cysteine proteases with 65% homology

with human

Cathepsin L.

The critical substitution that turns

proteolytic activity to silica polymerization is supposed to

be Cys to Ser substitution in the catalytic triad (Cys-His-

Asn). We synthesized a novel silica precursor for silicateins

– tetrakis(glycerol)orthosilicate (TGS). We have tested TGS

as a substrate for silicatein A1 from the marine sponge

Latrunculia oparinae. It effectively formed silica particles

with and the amount of polymerized silica 1000-fold greater

than previously described for silicatein alpha S.domuncula

and tetraethyl orthosilicate. Then we investigated the activity

of few silicatein point mutants – we substituted catalytic Ser

and its flanking residues to the residues from its cathepsin

homolog (S25C, Y26W, GAS23-25KSC). All the proteins retain

silicatein activity. Alaninemutants of the catalytic triad (S25A,

H163A, or N187A) still have silicatein activity. We hyposized

that mechanismof silicatein enzymatic activity involves some

other features of the protein and checked human cathepsin

L for the presence of silicatein activity. And found that it is

also capable to polymerise silica from TGS. So, new more

available precursor allowed us to find new enzymatic activity

of human cathepsin L and showed that our understanding of

silicatein activity mechanism call for reevaluation.

e:

povarovanv@gmail.com

An unexpected tolerance of silicatein activity to mutations revealed due to a novel water-soluble silica

precursor

Natalia V. Povarova

1

, Nikolay A. Barinov

2

, Nadezda M. Markina

1

, Mikhail S. Baranov

1

, Valery B. Kozhemyako

3

and

Konstantin A. Lukyanov

1

1

Institute of bioorganic chemistry, Russia

2

Federal Research and Clinical Center of Physical-Chemical Medicine, Russia

3

Pacific Institute of Bioorganic Chemistry, Russia